nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—HTR2A—enteric nervous system—Crohn's disease	0.0339	0.157	CbGeAlD
Haloperidol—HTR2A—myenteric nerve plexus—Crohn's disease	0.0257	0.119	CbGeAlD
Haloperidol—Cholestasis—Mercaptopurine—Crohn's disease	0.0128	0.0296	CcSEcCtD
Haloperidol—UGT1A9—digestive system—Crohn's disease	0.00821	0.038	CbGeAlD
Haloperidol—CBR1—skin of body—Crohn's disease	0.00772	0.0358	CbGeAlD
Haloperidol—Cholestasis—Azathioprine—Crohn's disease	0.00765	0.0176	CcSEcCtD
Haloperidol—Menorrhagia—Mesalazine—Crohn's disease	0.00715	0.0165	CcSEcCtD
Haloperidol—CBR1—mammalian vulva—Crohn's disease	0.00704	0.0326	CbGeAlD
Haloperidol—Cholestasis—Mesalazine—Crohn's disease	0.00697	0.016	CcSEcCtD
Haloperidol—H1F0—smooth muscle tissue—Crohn's disease	0.00641	0.0297	CbGeAlD
Haloperidol—Breast disorder—Mercaptopurine—Crohn's disease	0.00639	0.0147	CcSEcCtD
Haloperidol—H1F0—skin of body—Crohn's disease	0.00632	0.0293	CbGeAlD
Haloperidol—CBR1—lymphoid tissue—Crohn's disease	0.00625	0.029	CbGeAlD
Haloperidol—CBR1—digestive system—Crohn's disease	0.00617	0.0286	CbGeAlD
Haloperidol—Breast pain—Mesalazine—Crohn's disease	0.00606	0.014	CcSEcCtD
Haloperidol—Amenorrhoea—Mesalazine—Crohn's disease	0.00602	0.0139	CcSEcCtD
Haloperidol—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.0059	0.0136	CcSEcCtD
Haloperidol—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00582	0.0134	CcSEcCtD
Haloperidol—Pancytopenia—Mercaptopurine—Crohn's disease	0.00581	0.0134	CcSEcCtD
Haloperidol—H1F0—mammalian vulva—Crohn's disease	0.00577	0.0267	CbGeAlD
Haloperidol—Leukocytosis—Mesalazine—Crohn's disease	0.00563	0.013	CcSEcCtD
Haloperidol—CYP1A1—mouth—Crohn's disease	0.00555	0.0257	CbGeAlD
Haloperidol—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00516	0.0119	CcSEcCtD
Haloperidol—H1F0—lymphoid tissue—Crohn's disease	0.00512	0.0237	CbGeAlD
Haloperidol—H1F0—digestive system—Crohn's disease	0.00506	0.0235	CbGeAlD
Haloperidol—Menstruation irregular—Prednisone—Crohn's disease	0.00506	0.0116	CcSEcCtD
Haloperidol—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00482	0.0111	CcSEcCtD
Haloperidol—Hypertonia—Mesalazine—Crohn's disease	0.00464	0.0107	CcSEcCtD
Haloperidol—SIGMAR1—smooth muscle tissue—Crohn's disease	0.00463	0.0215	CbGeAlD
Haloperidol—HTR2B—smooth muscle tissue—Crohn's disease	0.00462	0.0214	CbGeAlD
Haloperidol—HTR2B—skin of body—Crohn's disease	0.00456	0.0211	CbGeAlD
Haloperidol—Immune system disorder—Mercaptopurine—Crohn's disease	0.00442	0.0102	CcSEcCtD
Haloperidol—Photosensitivity—Mesalazine—Crohn's disease	0.00437	0.0101	CcSEcCtD
Haloperidol—Alopecia—Mercaptopurine—Crohn's disease	0.00433	0.00997	CcSEcCtD
Haloperidol—Malnutrition—Mercaptopurine—Crohn's disease	0.00426	0.00982	CcSEcCtD
Haloperidol—SIGMAR1—mammalian vulva—Crohn's disease	0.00417	0.0193	CbGeAlD
Haloperidol—Libido decreased—Mesalazine—Crohn's disease	0.00414	0.00954	CcSEcCtD
Haloperidol—Anaemia—Mercaptopurine—Crohn's disease	0.00394	0.00907	CcSEcCtD
Haloperidol—Lethargy—Mesalazine—Crohn's disease	0.00392	0.00903	CcSEcCtD
Haloperidol—Leukopenia—Mercaptopurine—Crohn's disease	0.00381	0.00879	CcSEcCtD
Haloperidol—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00381	0.00878	CcSEcCtD
Haloperidol—Face oedema—Mesalazine—Crohn's disease	0.00371	0.00854	CcSEcCtD
Haloperidol—HTR2B—digestive system—Crohn's disease	0.00365	0.0169	CbGeAlD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0036	0.0083	CcSEcCtD
Haloperidol—Liver function test abnormal—Mesalazine—Crohn's disease	0.00355	0.00817	CcSEcCtD
Haloperidol—CBR1—lymph node—Crohn's disease	0.00353	0.0164	CbGeAlD
Haloperidol—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00351	0.00808	CcSEcCtD
Haloperidol—Oedema—Mercaptopurine—Crohn's disease	0.00348	0.00801	CcSEcCtD
Haloperidol—Breast disorder—Mesalazine—Crohn's disease	0.00347	0.008	CcSEcCtD
Haloperidol—Pancytopenia—Azathioprine—Crohn's disease	0.00346	0.00797	CcSEcCtD
Haloperidol—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.0034	0.00784	CcSEcCtD
Haloperidol—Skin disorder—Mercaptopurine—Crohn's disease	0.00338	0.00778	CcSEcCtD
Haloperidol—Endocrine disorder—Prednisone—Crohn's disease	0.00338	0.00778	CcSEcCtD
Haloperidol—Dysphagia—Mesalazine—Crohn's disease	0.00332	0.00765	CcSEcCtD
Haloperidol—Anorexia—Mercaptopurine—Crohn's disease	0.00331	0.00764	CcSEcCtD
Haloperidol—Bronchospasm—Mesalazine—Crohn's disease	0.00326	0.00752	CcSEcCtD
Haloperidol—CYP1A1—epithelium—Crohn's disease	0.00323	0.015	CbGeAlD
Haloperidol—Amenorrhoea—Prednisone—Crohn's disease	0.00319	0.00734	CcSEcCtD
Haloperidol—Pancytopenia—Mesalazine—Crohn's disease	0.00315	0.00726	CcSEcCtD
Haloperidol—Neutropenia—Mesalazine—Crohn's disease	0.0031	0.00715	CcSEcCtD
Haloperidol—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00307	0.00708	CcSEcCtD
Haloperidol—CYP1A1—skin of body—Crohn's disease	0.00307	0.0142	CbGeAlD
Haloperidol—HRH1—epithelium—Crohn's disease	0.00306	0.0142	CbGeAlD
Haloperidol—CYP2C19—digestive system—Crohn's disease	0.00305	0.0141	CbGeAlD
Haloperidol—Agranulocytosis—Azathioprine—Crohn's disease	0.00303	0.00699	CcSEcCtD
Haloperidol—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00303	0.00698	CcSEcCtD
Haloperidol—Decreased appetite—Mercaptopurine—Crohn's disease	0.00302	0.00696	CcSEcCtD
Haloperidol—Weight increased—Mesalazine—Crohn's disease	0.00302	0.00696	CcSEcCtD
Haloperidol—Weight decreased—Mesalazine—Crohn's disease	0.003	0.00692	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.003	0.00692	CcSEcCtD
Haloperidol—Leukocytosis—Prednisone—Crohn's disease	0.00298	0.00686	CcSEcCtD
Haloperidol—HRH1—smooth muscle tissue—Crohn's disease	0.00295	0.0137	CbGeAlD
Haloperidol—Depression—Mesalazine—Crohn's disease	0.00295	0.0068	CcSEcCtD
Haloperidol—Cataract—Prednisone—Crohn's disease	0.00294	0.00677	CcSEcCtD
Haloperidol—H1F0—lymph node—Crohn's disease	0.00289	0.0134	CbGeAlD
Haloperidol—Jaundice—Mesalazine—Crohn's disease	0.00288	0.00665	CcSEcCtD
Haloperidol—CYP1A1—mammalian vulva—Crohn's disease	0.0028	0.013	CbGeAlD
Haloperidol—Hepatobiliary disease—Mesalazine—Crohn's disease	0.0028	0.00645	CcSEcCtD
Haloperidol—Agranulocytosis—Mesalazine—Crohn's disease	0.00276	0.00636	CcSEcCtD
Haloperidol—Body temperature increased—Mercaptopurine—Crohn's disease	0.00275	0.00633	CcSEcCtD
Haloperidol—HRH1—mammalian vulva—Crohn's disease	0.00266	0.0123	CbGeAlD
Haloperidol—Hepatitis—Mesalazine—Crohn's disease	0.00266	0.00612	CcSEcCtD
Haloperidol—Immune system disorder—Azathioprine—Crohn's disease	0.00263	0.00607	CcSEcCtD
Haloperidol—Mediastinal disorder—Azathioprine—Crohn's disease	0.00263	0.00606	CcSEcCtD
Haloperidol—Urinary tract disorder—Mesalazine—Crohn's disease	0.00262	0.00604	CcSEcCtD
Haloperidol—Connective tissue disorder—Mesalazine—Crohn's disease	0.00261	0.00601	CcSEcCtD
Haloperidol—Urethral disorder—Mesalazine—Crohn's disease	0.0026	0.006	CcSEcCtD
Haloperidol—Alopecia—Azathioprine—Crohn's disease	0.00258	0.00594	CcSEcCtD
Haloperidol—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00256	0.0059	CcSEcCtD
Haloperidol—HTR2A—epithelium—Crohn's disease	0.00256	0.0119	CbGeAlD
Haloperidol—CYP1A2—digestive system—Crohn's disease	0.00249	0.0115	CbGeAlD
Haloperidol—Eye disorder—Mesalazine—Crohn's disease	0.00248	0.00572	CcSEcCtD
Haloperidol—HTR2A—smooth muscle tissue—Crohn's disease	0.00247	0.0114	CbGeAlD
Haloperidol—Cardiac disorder—Mesalazine—Crohn's disease	0.00247	0.00568	CcSEcCtD
Haloperidol—CYP1A1—digestive system—Crohn's disease	0.00246	0.0114	CbGeAlD
Haloperidol—Hyperkinesia—Prednisone—Crohn's disease	0.00244	0.00562	CcSEcCtD
Haloperidol—Angiopathy—Mesalazine—Crohn's disease	0.00241	0.00555	CcSEcCtD
Haloperidol—Euphoric mood—Prednisone—Crohn's disease	0.0024	0.00554	CcSEcCtD
Haloperidol—CYP3A5—digestive system—Crohn's disease	0.0024	0.0111	CbGeAlD
Haloperidol—Immune system disorder—Mesalazine—Crohn's disease	0.0024	0.00553	CcSEcCtD
Haloperidol—Mediastinal disorder—Mesalazine—Crohn's disease	0.00239	0.00552	CcSEcCtD
Haloperidol—Diarrhoea—Mercaptopurine—Crohn's disease	0.00238	0.00548	CcSEcCtD
Haloperidol—CYP2C9—digestive system—Crohn's disease	0.00236	0.011	CbGeAlD
Haloperidol—Alopecia—Mesalazine—Crohn's disease	0.00235	0.00541	CcSEcCtD
Haloperidol—Anaemia—Azathioprine—Crohn's disease	0.00235	0.00541	CcSEcCtD
Haloperidol—HRH1—digestive system—Crohn's disease	0.00233	0.0108	CbGeAlD
Haloperidol—Mental disorder—Mesalazine—Crohn's disease	0.00233	0.00536	CcSEcCtD
Haloperidol—Leukopenia—Azathioprine—Crohn's disease	0.00227	0.00524	CcSEcCtD
Haloperidol—Muscle spasms—Mesalazine—Crohn's disease	0.00222	0.00512	CcSEcCtD
Haloperidol—Vomiting—Mercaptopurine—Crohn's disease	0.00221	0.00509	CcSEcCtD
Haloperidol—Rash—Mercaptopurine—Crohn's disease	0.00219	0.00505	CcSEcCtD
Haloperidol—Dermatitis—Mercaptopurine—Crohn's disease	0.00219	0.00505	CcSEcCtD
Haloperidol—Vision blurred—Mesalazine—Crohn's disease	0.00218	0.00502	CcSEcCtD
Haloperidol—Tremor—Mesalazine—Crohn's disease	0.00217	0.00499	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00215	0.00495	CcSEcCtD
Haloperidol—Anaemia—Mesalazine—Crohn's disease	0.00214	0.00492	CcSEcCtD
Haloperidol—SIGMAR1—lymph node—Crohn's disease	0.00209	0.00968	CbGeAlD
Haloperidol—HTR2B—lymph node—Crohn's disease	0.00208	0.00965	CbGeAlD
Haloperidol—Vertigo—Mesalazine—Crohn's disease	0.00208	0.00479	CcSEcCtD
Haloperidol—Lethargy—Prednisone—Crohn's disease	0.00207	0.00478	CcSEcCtD
Haloperidol—Leukopenia—Mesalazine—Crohn's disease	0.00207	0.00477	CcSEcCtD
Haloperidol—Nausea—Mercaptopurine—Crohn's disease	0.00207	0.00476	CcSEcCtD
Haloperidol—Thrombocytopenia—Azathioprine—Crohn's disease	0.00203	0.00467	CcSEcCtD
Haloperidol—Skin disorder—Azathioprine—Crohn's disease	0.00201	0.00464	CcSEcCtD
Haloperidol—Hypertension—Mesalazine—Crohn's disease	0.002	0.0046	CcSEcCtD
Haloperidol—Psychotic disorder—Prednisone—Crohn's disease	0.00198	0.00457	CcSEcCtD
Haloperidol—Anxiety—Mesalazine—Crohn's disease	0.00196	0.00452	CcSEcCtD
Haloperidol—Face oedema—Prednisone—Crohn's disease	0.00196	0.00452	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00196	0.0045	CcSEcCtD
Haloperidol—HTR2A—digestive system—Crohn's disease	0.00195	0.00903	CbGeAlD
Haloperidol—Hypotension—Azathioprine—Crohn's disease	0.00194	0.00446	CcSEcCtD
Haloperidol—Cardiac arrest—Prednisone—Crohn's disease	0.00193	0.00445	CcSEcCtD
Haloperidol—Dry mouth—Mesalazine—Crohn's disease	0.00193	0.00444	CcSEcCtD
Haloperidol—Confusional state—Mesalazine—Crohn's disease	0.0019	0.00438	CcSEcCtD
Haloperidol—Oedema—Mesalazine—Crohn's disease	0.00189	0.00435	CcSEcCtD
Haloperidol—Anaphylactic shock—Mesalazine—Crohn's disease	0.00189	0.00435	CcSEcCtD
Haloperidol—Nervous system disorder—Mesalazine—Crohn's disease	0.00185	0.00426	CcSEcCtD
Haloperidol—Thrombocytopenia—Mesalazine—Crohn's disease	0.00185	0.00426	CcSEcCtD
Haloperidol—Tachycardia—Mesalazine—Crohn's disease	0.00184	0.00424	CcSEcCtD
Haloperidol—Skin disorder—Mesalazine—Crohn's disease	0.00183	0.00422	CcSEcCtD
Haloperidol—Hyperhidrosis—Mesalazine—Crohn's disease	0.00182	0.0042	CcSEcCtD
Haloperidol—CYP3A4—digestive system—Crohn's disease	0.0018	0.00836	CbGeAlD
Haloperidol—Anorexia—Mesalazine—Crohn's disease	0.0018	0.00414	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00179	0.00412	CcSEcCtD
Haloperidol—CYP2D6—digestive system—Crohn's disease	0.00177	0.00822	CbGeAlD
Haloperidol—Hypotension—Mesalazine—Crohn's disease	0.00176	0.00406	CcSEcCtD
Haloperidol—Sweating increased—Prednisone—Crohn's disease	0.00171	0.00394	CcSEcCtD
Haloperidol—Feeling abnormal—Azathioprine—Crohn's disease	0.00171	0.00393	CcSEcCtD
Haloperidol—Insomnia—Mesalazine—Crohn's disease	0.00171	0.00393	CcSEcCtD
Haloperidol—Dyspnoea—Mesalazine—Crohn's disease	0.00168	0.00388	CcSEcCtD
Haloperidol—Somnolence—Mesalazine—Crohn's disease	0.00168	0.00387	CcSEcCtD
Haloperidol—ABCB1—epithelium—Crohn's disease	0.00168	0.00777	CbGeAlD
Haloperidol—Dyspepsia—Mesalazine—Crohn's disease	0.00166	0.00383	CcSEcCtD
Haloperidol—KCNH2—lymph node—Crohn's disease	0.00166	0.0077	CbGeAlD
Haloperidol—Neutropenia—Prednisone—Crohn's disease	0.00164	0.00378	CcSEcCtD
Haloperidol—Decreased appetite—Mesalazine—Crohn's disease	0.00164	0.00378	CcSEcCtD
Haloperidol—Body temperature increased—Azathioprine—Crohn's disease	0.00164	0.00377	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00163	0.00375	CcSEcCtD
Haloperidol—Erectile dysfunction—Prednisone—Crohn's disease	0.00162	0.00373	CcSEcCtD
Haloperidol—Constipation—Mesalazine—Crohn's disease	0.00161	0.00372	CcSEcCtD
Haloperidol—Weight increased—Prednisone—Crohn's disease	0.0016	0.00368	CcSEcCtD
Haloperidol—Weight decreased—Prednisone—Crohn's disease	0.00159	0.00366	CcSEcCtD
Haloperidol—Hyperglycaemia—Prednisone—Crohn's disease	0.00158	0.00365	CcSEcCtD
Haloperidol—Depression—Prednisone—Crohn's disease	0.00156	0.0036	CcSEcCtD
Haloperidol—Feeling abnormal—Mesalazine—Crohn's disease	0.00156	0.00358	CcSEcCtD
Haloperidol—Hypersensitivity—Azathioprine—Crohn's disease	0.00153	0.00352	CcSEcCtD
Haloperidol—Urticaria—Mesalazine—Crohn's disease	0.0015	0.00345	CcSEcCtD
Haloperidol—Body temperature increased—Mesalazine—Crohn's disease	0.00149	0.00344	CcSEcCtD
Haloperidol—ABCB1—mammalian vulva—Crohn's disease	0.00145	0.00674	CbGeAlD
Haloperidol—Diarrhoea—Azathioprine—Crohn's disease	0.00142	0.00327	CcSEcCtD
Haloperidol—CYP1A1—lymph node—Crohn's disease	0.0014	0.0065	CbGeAlD
Haloperidol—Hallucination—Prednisone—Crohn's disease	0.0014	0.00322	CcSEcCtD
Haloperidol—Hypersensitivity—Mesalazine—Crohn's disease	0.00139	0.0032	CcSEcCtD
Haloperidol—Connective tissue disorder—Prednisone—Crohn's disease	0.00138	0.00318	CcSEcCtD
Haloperidol—Dizziness—Azathioprine—Crohn's disease	0.00137	0.00316	CcSEcCtD
Haloperidol—Pruritus—Mesalazine—Crohn's disease	0.00134	0.00308	CcSEcCtD
Haloperidol—HRH1—lymph node—Crohn's disease	0.00133	0.00617	CbGeAlD
Haloperidol—Vomiting—Azathioprine—Crohn's disease	0.00132	0.00304	CcSEcCtD
Haloperidol—Eye disorder—Prednisone—Crohn's disease	0.00131	0.00303	CcSEcCtD
Haloperidol—Rash—Azathioprine—Crohn's disease	0.00131	0.00301	CcSEcCtD
Haloperidol—Dermatitis—Azathioprine—Crohn's disease	0.00131	0.00301	CcSEcCtD
Haloperidol—Headache—Azathioprine—Crohn's disease	0.0013	0.00299	CcSEcCtD
Haloperidol—ABCB1—lymphoid tissue—Crohn's disease	0.00129	0.00599	CbGeAlD
Haloperidol—Diarrhoea—Mesalazine—Crohn's disease	0.00129	0.00298	CcSEcCtD
Haloperidol—ABCB1—digestive system—Crohn's disease	0.00128	0.00591	CbGeAlD
Haloperidol—Angiopathy—Prednisone—Crohn's disease	0.00128	0.00294	CcSEcCtD
Haloperidol—Immune system disorder—Prednisone—Crohn's disease	0.00127	0.00293	CcSEcCtD
Haloperidol—Dizziness—Mesalazine—Crohn's disease	0.00125	0.00288	CcSEcCtD
Haloperidol—Alopecia—Prednisone—Crohn's disease	0.00124	0.00286	CcSEcCtD
Haloperidol—Mental disorder—Prednisone—Crohn's disease	0.00123	0.00284	CcSEcCtD
Haloperidol—Nausea—Azathioprine—Crohn's disease	0.00123	0.00284	CcSEcCtD
Haloperidol—Malnutrition—Prednisone—Crohn's disease	0.00122	0.00282	CcSEcCtD
Haloperidol—Vomiting—Mesalazine—Crohn's disease	0.0012	0.00276	CcSEcCtD
Haloperidol—Rash—Mesalazine—Crohn's disease	0.00119	0.00274	CcSEcCtD
Haloperidol—Dermatitis—Mesalazine—Crohn's disease	0.00119	0.00274	CcSEcCtD
Haloperidol—Headache—Mesalazine—Crohn's disease	0.00118	0.00272	CcSEcCtD
Haloperidol—Vision blurred—Prednisone—Crohn's disease	0.00115	0.00266	CcSEcCtD
Haloperidol—Anaemia—Prednisone—Crohn's disease	0.00113	0.00261	CcSEcCtD
Haloperidol—Agitation—Prednisone—Crohn's disease	0.00112	0.00259	CcSEcCtD
Haloperidol—Nausea—Mesalazine—Crohn's disease	0.00112	0.00258	CcSEcCtD
Haloperidol—Vertigo—Prednisone—Crohn's disease	0.0011	0.00253	CcSEcCtD
Haloperidol—Convulsion—Prednisone—Crohn's disease	0.00106	0.00244	CcSEcCtD
Haloperidol—Hypertension—Prednisone—Crohn's disease	0.00106	0.00243	CcSEcCtD
Haloperidol—Anxiety—Prednisone—Crohn's disease	0.00104	0.00239	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00103	0.00238	CcSEcCtD
Haloperidol—Anaphylactic shock—Prednisone—Crohn's disease	0.000999	0.0023	CcSEcCtD
Haloperidol—Oedema—Prednisone—Crohn's disease	0.000999	0.0023	CcSEcCtD
Haloperidol—Nervous system disorder—Prednisone—Crohn's disease	0.000979	0.00226	CcSEcCtD
Haloperidol—Tachycardia—Prednisone—Crohn's disease	0.000975	0.00225	CcSEcCtD
Haloperidol—Skin disorder—Prednisone—Crohn's disease	0.00097	0.00223	CcSEcCtD
Haloperidol—Hyperhidrosis—Prednisone—Crohn's disease	0.000965	0.00222	CcSEcCtD
Haloperidol—Anorexia—Prednisone—Crohn's disease	0.000952	0.00219	CcSEcCtD
Haloperidol—Insomnia—Prednisone—Crohn's disease	0.000903	0.00208	CcSEcCtD
Haloperidol—Dyspepsia—Prednisone—Crohn's disease	0.000879	0.00203	CcSEcCtD
Haloperidol—Decreased appetite—Prednisone—Crohn's disease	0.000868	0.002	CcSEcCtD
Haloperidol—Constipation—Prednisone—Crohn's disease	0.000854	0.00197	CcSEcCtD
Haloperidol—Feeling abnormal—Prednisone—Crohn's disease	0.000823	0.0019	CcSEcCtD
Haloperidol—Urticaria—Prednisone—Crohn's disease	0.000793	0.00183	CcSEcCtD
Haloperidol—Body temperature increased—Prednisone—Crohn's disease	0.000789	0.00182	CcSEcCtD
Haloperidol—Hypersensitivity—Prednisone—Crohn's disease	0.000736	0.0017	CcSEcCtD
Haloperidol—ABCB1—lymph node—Crohn's disease	0.000729	0.00338	CbGeAlD
Haloperidol—Pruritus—Prednisone—Crohn's disease	0.000706	0.00163	CcSEcCtD
Haloperidol—Diarrhoea—Prednisone—Crohn's disease	0.000683	0.00157	CcSEcCtD
Haloperidol—Dizziness—Prednisone—Crohn's disease	0.00066	0.00152	CcSEcCtD
Haloperidol—Vomiting—Prednisone—Crohn's disease	0.000635	0.00146	CcSEcCtD
Haloperidol—Rash—Prednisone—Crohn's disease	0.00063	0.00145	CcSEcCtD
Haloperidol—Dermatitis—Prednisone—Crohn's disease	0.000629	0.00145	CcSEcCtD
Haloperidol—Headache—Prednisone—Crohn's disease	0.000626	0.00144	CcSEcCtD
Haloperidol—Nausea—Prednisone—Crohn's disease	0.000593	0.00137	CcSEcCtD
Haloperidol—HTR1D—Signaling Pathways—UBE2D1—Crohn's disease	0.000106	0.000302	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000106	0.000301	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000105	0.000301	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000105	0.0003	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RBX1—Crohn's disease	0.000105	0.000299	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—UBE2D1—Crohn's disease	0.000104	0.000296	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RBX1—Crohn's disease	0.000103	0.000295	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000103	0.000295	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000103	0.000294	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	0.000103	0.000294	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RIPK2—Crohn's disease	0.000103	0.000293	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTMR3—Crohn's disease	0.000102	0.000292	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GCKR—Crohn's disease	0.000102	0.000292	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—UBE2D1—Crohn's disease	0.000102	0.000291	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000102	0.000291	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL2RA—Crohn's disease	0.000102	0.00029	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—IL6—Crohn's disease	0.000101	0.000288	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PTGER4—Crohn's disease	0.000101	0.000287	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RIPK2—Crohn's disease	0.0001	0.000287	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GPX4—Crohn's disease	0.0001	0.000286	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL3—Crohn's disease	0.0001	0.000286	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RIPK2—Crohn's disease	9.89e-05	0.000282	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL3—Crohn's disease	9.8e-05	0.00028	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—IL6—Crohn's disease	9.76e-05	0.000279	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—UBE2D1—Crohn's disease	9.73e-05	0.000278	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RASGRP1—Crohn's disease	9.68e-05	0.000276	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GCKR—Crohn's disease	9.66e-05	0.000276	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL3—Crohn's disease	9.64e-05	0.000275	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RASGRP1—Crohn's disease	9.48e-05	0.00027	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RIPK2—Crohn's disease	9.44e-05	0.000269	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RASGRP1—Crohn's disease	9.32e-05	0.000266	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	9.29e-05	0.000265	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL3—Crohn's disease	9.2e-05	0.000263	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—UBE2D1—Crohn's disease	9.18e-05	0.000262	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	9.14e-05	0.000261	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	9.12e-05	0.00026	CbGpPWpGaD
Haloperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.1e-05	0.00026	CbGpPWpGaD
Haloperidol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.08e-05	0.000259	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—UBE2D1—Crohn's disease	9.06e-05	0.000258	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RASGRP1—Crohn's disease	8.9e-05	0.000254	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RIPK2—Crohn's disease	8.9e-05	0.000254	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—JAK2—Crohn's disease	8.78e-05	0.000251	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RIPK2—Crohn's disease	8.78e-05	0.000251	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SOCS1—Crohn's disease	8.77e-05	0.00025	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTMR3—Crohn's disease	8.75e-05	0.00025	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—FADS1—Crohn's disease	8.74e-05	0.00025	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCR6—Crohn's disease	8.74e-05	0.000249	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL3—Crohn's disease	8.68e-05	0.000248	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—JAK2—Crohn's disease	8.6e-05	0.000245	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCR6—Crohn's disease	8.6e-05	0.000245	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SOCS1—Crohn's disease	8.58e-05	0.000245	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCR6—Crohn's disease	8.58e-05	0.000245	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL3—Crohn's disease	8.56e-05	0.000244	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	8.56e-05	0.000244	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—FADS1—Crohn's disease	8.54e-05	0.000244	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—JAK2—Crohn's disease	8.46e-05	0.000242	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SOCS1—Crohn's disease	8.45e-05	0.000241	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	8.42e-05	0.00024	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	8.4e-05	0.00024	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RASGRP1—Crohn's disease	8.39e-05	0.00024	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—TYK2—Crohn's disease	8.36e-05	0.000239	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RASGRP1—Crohn's disease	8.28e-05	0.000236	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GPX4—Crohn's disease	8.19e-05	0.000234	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	8.18e-05	0.000234	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	8.08e-05	0.000231	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	8.06e-05	0.00023	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—TYK2—Crohn's disease	8.05e-05	0.00023	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—FADS1—Crohn's disease	8.04e-05	0.00023	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—CXCL8—Crohn's disease	8.01e-05	0.000229	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GPX4—Crohn's disease	7.99e-05	0.000228	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—JAK2—Crohn's disease	7.97e-05	0.000228	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—FADS1—Crohn's disease	7.97e-05	0.000228	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	7.94e-05	0.000227	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GCKR—Crohn's disease	7.91e-05	0.000226	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RBX1—Crohn's disease	7.9e-05	0.000226	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	7.85e-05	0.000224	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	7.81e-05	0.000223	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	7.8e-05	0.000223	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RBX1—Crohn's disease	7.78e-05	0.000222	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	7.77e-05	0.000222	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RBX1—Crohn's disease	7.76e-05	0.000221	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—CXCL8—Crohn's disease	7.72e-05	0.00022	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GCKR—Crohn's disease	7.72e-05	0.00022	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PTGER4—Crohn's disease	7.69e-05	0.00022	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	7.69e-05	0.000219	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—JAK2—Crohn's disease	7.68e-05	0.000219	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	7.65e-05	0.000218	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	7.63e-05	0.000218	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	7.62e-05	0.000217	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SOCS1—Crohn's disease	7.6e-05	0.000217	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SMAD3—Crohn's disease	7.57e-05	0.000216	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	7.57e-05	0.000216	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PTGER4—Crohn's disease	7.55e-05	0.000216	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GPX4—Crohn's disease	7.53e-05	0.000215	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	7.52e-05	0.000215	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SOCS1—Crohn's disease	7.5e-05	0.000214	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GPX4—Crohn's disease	7.47e-05	0.000213	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	7.41e-05	0.000212	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	7.37e-05	0.00021	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	7.33e-05	0.000209	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SMAD3—Crohn's disease	7.29e-05	0.000208	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	7.28e-05	0.000208	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GCKR—Crohn's disease	7.27e-05	0.000208	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—TYK2—Crohn's disease	7.25e-05	0.000207	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GCKR—Crohn's disease	7.21e-05	0.000206	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—TYK2—Crohn's disease	7.15e-05	0.000204	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	7.13e-05	0.000203	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	7.01e-05	0.0002	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	7.01e-05	0.0002	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	6.96e-05	0.000199	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	6.95e-05	0.000198	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	6.93e-05	0.000198	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—JAK2—Crohn's disease	6.92e-05	0.000197	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.91e-05	0.000197	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	6.86e-05	0.000196	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	6.86e-05	0.000196	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—JAK2—Crohn's disease	6.82e-05	0.000195	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	6.82e-05	0.000195	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—FADS1—Crohn's disease	6.81e-05	0.000195	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	6.8e-05	0.000194	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL2RA—Crohn's disease	6.75e-05	0.000193	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTMR3—Crohn's disease	6.75e-05	0.000193	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RIPK2—Crohn's disease	6.72e-05	0.000192	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	6.69e-05	0.000191	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	6.61e-05	0.000189	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RIPK2—Crohn's disease	6.6e-05	0.000188	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SMAD3—Crohn's disease	6.57e-05	0.000187	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL3—Crohn's disease	6.55e-05	0.000187	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SMAD3—Crohn's disease	6.48e-05	0.000185	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL3—Crohn's disease	6.45e-05	0.000184	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	6.45e-05	0.000184	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL3—Crohn's disease	6.43e-05	0.000184	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GPX4—Crohn's disease	6.38e-05	0.000182	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	6.34e-05	0.000181	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	6.31e-05	0.00018	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	6.24e-05	0.000178	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	6.23e-05	0.000178	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	6.22e-05	0.000178	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GCKR—Crohn's disease	6.16e-05	0.000176	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL2RA—Crohn's disease	6.08e-05	0.000174	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.04e-05	0.000172	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL2RA—Crohn's disease	6e-05	0.000171	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	5.75e-05	0.000164	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SOCS1—Crohn's disease	5.74e-05	0.000164	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	5.66e-05	0.000162	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.65e-05	0.000161	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	5.65e-05	0.000161	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	5.65e-05	0.000161	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SOCS1—Crohn's disease	5.64e-05	0.000161	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—TYK2—Crohn's disease	5.47e-05	0.000156	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	5.39e-05	0.000154	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—TYK2—Crohn's disease	5.37e-05	0.000153	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—ALB—Crohn's disease	5.36e-05	0.000153	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—FADS1—Crohn's disease	5.26e-05	0.00015	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	5.25e-05	0.00015	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.25e-05	0.00015	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—JAK2—Crohn's disease	5.22e-05	0.000149	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	5.16e-05	0.000147	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	5.15e-05	0.000147	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.15e-05	0.000147	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	5.14e-05	0.000147	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—JAK2—Crohn's disease	5.13e-05	0.000146	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SMAD3—Crohn's disease	4.96e-05	0.000142	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.94e-05	0.000141	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TYK2—Crohn's disease	4.94e-05	0.000141	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GPX4—Crohn's disease	4.92e-05	0.000141	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	4.88e-05	0.000139	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SMAD3—Crohn's disease	4.87e-05	0.000139	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TYK2—Crohn's disease	4.84e-05	0.000138	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	4.77e-05	0.000136	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TYK2—Crohn's disease	4.76e-05	0.000136	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GCKR—Crohn's disease	4.76e-05	0.000136	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—JAK2—Crohn's disease	4.71e-05	0.000134	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	4.69e-05	0.000134	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTGS2—Crohn's disease	4.69e-05	0.000134	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	4.68e-05	0.000134	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—JAK2—Crohn's disease	4.61e-05	0.000132	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL2RA—Crohn's disease	4.59e-05	0.000131	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TYK2—Crohn's disease	4.54e-05	0.00013	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—JAK2—Crohn's disease	4.54e-05	0.00013	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	4.52e-05	0.000129	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.51e-05	0.000129	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL2RA—Crohn's disease	4.51e-05	0.000129	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ALB—Crohn's disease	4.5e-05	0.000129	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.4e-05	0.000126	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—JAK2—Crohn's disease	4.33e-05	0.000124	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	4.3e-05	0.000123	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TYK2—Crohn's disease	4.28e-05	0.000122	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TYK2—Crohn's disease	4.23e-05	0.000121	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	4.21e-05	0.00012	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CXCL8—Crohn's disease	4.14e-05	0.000118	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL6—Crohn's disease	4.09e-05	0.000117	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—JAK2—Crohn's disease	4.09e-05	0.000117	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—JAK2—Crohn's disease	4.03e-05	0.000115	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL6—Crohn's disease	4e-05	0.000114	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	3.95e-05	0.000113	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—Crohn's disease	3.94e-05	0.000112	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL6—Crohn's disease	3.94e-05	0.000112	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.85e-05	0.00011	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL6—Crohn's disease	3.76e-05	0.000107	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CXCL8—Crohn's disease	3.73e-05	0.000106	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CXCL8—Crohn's disease	3.68e-05	0.000105	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—Crohn's disease	3.55e-05	0.000101	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—Crohn's disease	3.5e-05	9.99e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—STAT3—Crohn's disease	3.46e-05	9.87e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—STAT3—Crohn's disease	3.39e-05	9.66e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—STAT3—Crohn's disease	3.33e-05	9.51e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—Crohn's disease	3.26e-05	9.29e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TYK2—Crohn's disease	3.23e-05	9.23e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TYK2—Crohn's disease	3.18e-05	9.08e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—STAT3—Crohn's disease	3.18e-05	9.08e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TYK2—Crohn's disease	3.18e-05	9.06e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—JAK2—Crohn's disease	3.09e-05	8.81e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—Crohn's disease	3.08e-05	8.78e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—JAK2—Crohn's disease	3.04e-05	8.67e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—JAK2—Crohn's disease	3.03e-05	8.65e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—STAT3—Crohn's disease	3e-05	8.56e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—STAT3—Crohn's disease	2.96e-05	8.45e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.85e-05	8.13e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.82e-05	8.04e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.77e-05	7.91e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.76e-05	7.89e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—Crohn's disease	2.69e-05	7.68e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.68e-05	7.64e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.63e-05	7.52e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.63e-05	7.5e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—Crohn's disease	2.52e-05	7.19e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—Crohn's disease	2.46e-05	7.01e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—Crohn's disease	2.42e-05	6.89e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—Crohn's disease	2.36e-05	6.75e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—Crohn's disease	2.33e-05	6.64e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—Crohn's disease	2.32e-05	6.61e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—Crohn's disease	2.29e-05	6.55e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—STAT3—Crohn's disease	2.26e-05	6.46e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—STAT3—Crohn's disease	2.23e-05	6.36e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—STAT3—Crohn's disease	2.22e-05	6.35e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—Crohn's disease	2.22e-05	6.34e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—Crohn's disease	2.2e-05	6.29e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—Crohn's disease	2.15e-05	6.14e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—Crohn's disease	2.09e-05	5.98e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—Crohn's disease	2.07e-05	5.9e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.03e-05	5.78e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.01e-05	5.73e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—Crohn's disease	1.96e-05	5.6e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.72e-05	4.9e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—Crohn's disease	1.58e-05	4.52e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.56e-05	4.44e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—Crohn's disease	1.55e-05	4.43e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—Crohn's disease	1.51e-05	4.32e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.32e-05	3.78e-05	CbGpPWpGaD
